secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2023-10-10T23:59:59+00:00
Accession:  0001731122-23-001841
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renovaro raises $2M via 5% OID convertible notes at 12% interest, due Sept 2024
-------------------------------------------------------------------------------

- Aggregate principal $2,105,264; gross proceeds $2,000,000 after 5% original issue discount.
- Notes bear 12% annual interest and mature September 5, 2024; convertible only upon Qualified Offering (≥$10M) or at maturity.
- Conversion price at 95% of Qualified Offering price or closing price at maturity, subject to floor of $4.50 per share.
- One note issued Sept 5, 2023 for $526,316 has a floor at 105% of Nasdaq closing price preceding issuance.
- Notes sold to five non-U.S. persons under Regulation S; proceeds for therapy development and working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112223001841/0001731122-23-001841-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112223001841/e5116_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-23-001841

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer